Obesity: From Cell to Patient | EK17
GIPR Antagonist Antibodies Conjugated to GLP-1 Peptides Decrease Weight in Obese Preclinical Models
Feb 1, 2021 6:40pm ‐ Feb 1, 2021 7:05pm
Murielle M. Veniant
, PhD, Amgen Inc.
You must be logged in and own this session in order to post comments.
© 2021 Keystone Symposia & Digitell, Inc. All Rights Reserved